Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice

Molecular Brain Research

Volumn 69, Issue 1, 1999, Pages 135-143

  Yang, Guo Yuan ^a   Gong, Chao ^a,b   Qin, Zhen ^b   Liu, Xiao Hong ^a   Lorris Betz, A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Blood brain barrier; Ischemia; Middle cerebral artery occlusion; Reperfusion; Temporary; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN SLICE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOFLUORESCENCE TEST; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; REPERFUSION;

AGE FACTORS; ANIMALS; ANTIBODIES; ARTERIAL OCCLUSIVE DISEASES; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED STRAINS; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032964243     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00007-8     Document Type: Article

References (39)

1. Akassoglou K., Probert L., Kontogeorgos G., Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:1997;438-445.
2. Albayrak S., Zhao Q., Siesjo B.K., Smith M.L. Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury. Acta Neuropathologica. 94:1997;158-163.
3. Ames A., Wright L., Kowade M., Thurston J.M., Majors G. Cerebral ischemia: the no-flow phenominen. Am. J. Pathol. 52:1968;437-453.
4. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
5. Betz A.L. Alterations in cerebral endothelial cell function in ischemia. Adv. Neurol. 71:1996;301-311. discussion 311-313.
6. Buttini M., Appel K., Sauter A., Gebicke-Haerter P.J., Boddeke H.W.G.M. Expression of tumor necrosis factor alpha after focal cerebral ischemia in rat. Neuroscience. 71:1996;1-16.
7. Clark W.M., Madden K.P., Rothlein R., Zivin J.R. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. 75:1991;623-627.
8. Cole D.J., Matsumura J.S., Drummond J.C., Schultz R.L., Wong M.H. Time- and pressure-dependent changes in blood-brain barrier permeability after temporary middle cerebral artery occlusion in rats. Acta Neuropathol. (Berl.). 82:1991;266-273.
9. Deli M.A., Descamps L., Dehouck M.P., Cecchelli R., Joo F., Abraham C.S., Torpier G. Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J. Neurosci. Res. 41:1995;717-726.
10. 14C -AIB J. Cereb. Blood Flow Metab. 9:1989;71-78.
11. Feuerstein G.Z., Liu T., Barone F.C. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. Brain Metab. Rev. 6:1994;341-360.
12. Hallenbeck J.M., Dutka A.J. Background review and current concepts of reperfusion injury. Arch. Neurol. 47:1990;1245-1254.
13. Harlan J.M. Leukocyte-endothelial interactions. Blood. 65:1985;513-525.
14. Harlan J.M. Neutrophil-mediated vascular injury. Acta Med. Scand., Suppl. 715:1987;123-129.
15. Janzer R.C., Raff M.C. Astrocytes induce blood-brain barrier characteristics in cerebral endothelial cells. Nature. 325:1987;253-257.
16. Kawagoe J., Abe K., Ikuta J., Igareshi N., Shimizu S., Yamauchi Y., Kogure K. Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats: a quantitative study. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;485-488.
17. Kim K.S., Wass C.A., Cross A., Opal S.M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 11:1992;293-298.
18. Kitagawa K., Matsumoto M., Tagaya M., Ueda H., Oku N., Kuwabara K., Ohtsuki T., Handa N., Kimura K., Kamada T. Temporal profile of serum albumin extravasation following cerebral ischemia in a newly established reproducible gerbil model for vasogenic brain edema: a combined immunohistochemical and dye tracer analysis. Acta Neuropathol. (Berl.). 82:1991;164-171.
19. Kuroiwa T., Shibutani M., Okeda R. Blood-brain disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemia. Acta Neuropathol. (Berl.). 76:1988;62-70.
20. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor-α expression in ischemic neurons. Stroke. 25:1994;1481-1488.
21. Medana I.M., Hunt N.H., Chaudhri G. Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am. J. Pathol. 150:1997;1473-1486.
22. Megyeri P., Abraham C.S., Temesvari P., Kovacs J., Vas T., Speer C.P. Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in new piglets. Neurosci. Lett. 148:1992;137-140.
23. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci. Lett. 165:1994;208-210.
24. Nawashiro H., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J. Cereb. Blood Flow Metab. 17:1997;229-232.
25. Sadoshima S., Fujishima M., Ogata J., Ibayashi S., Shiokawa O., Omae T. Disruption of blood-brain barrier following bilateral carotid artery occlusion in spontaneously hypertensive rats. Stroke. 14:1983;876-882.
26. Sage J.I., Van Uitert R.L., Duffy T.E. Early changes in blood brain barrier permeability to small molecules after transient cerebral ischemia. Stroke. 15:1984;46-50.
27. Schell R.M., Cole D.J., Schultz R.L., Osborne T.N. Temporary cerebral ischemia: Effects of pentastarch or albumin on reperfusion injury. Anesthesiology. 77:1992;86-92.
28. Sharief M.K., Ciardi M., Thompson E.J. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J. Infect. Dis. 166:1992;350-358.
29. Sharief M.K., Thompson E.J. In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38:1992;27-33.
30. Shohami E., Bass R., Wallach D., Yamin A., Gallily R. Inhibition of tumor necrosis factor alpha (TNFα) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16:1996;378-384.
31. Tarlow M.J., Jenkins R., Comis S.D., Osborne M.P., Stephens S., Stanley P., Crocker J. Ependymal cells of the choroid plexus express tumour necrosis factor-alpha. Neuropathol. Appl. Neurobiol. 19:1993;324-328.
32. Tibbling G., Link H., Ohman S. Principles of albumin and IgG analyses in neurological disorders: I. Establishment of reference values. Scandinavian Journal of Clinical and Laboratory Investigation. 37:1977;385-390.
33. Uno H., Matsuyama T., Akita H., Nishimura H., Sugita M. Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 17:1997;491-499.
34. Wang X., Yue T.L., Barone F.C., White R.F., Gagnon R.C., Feuerstein G.Z. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23:1994;103-114.
35. Wong D., Dorovini Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39:1992;11-22.
36. Yang G., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., Epstein C.J., Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 25:1994;165-170.
37. Yang G.-Y., Betz A.L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke. 25:1994;1658-1664.
38. Yang G.Y., Gong C., Qin Z., Ye W., Mao Y., Betz A.L. Inhibition of TNFa attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport. 9:1998;2131-2134.
39. Zhang R.L., Chopp M., Li Y., Zaloga C., Jiang N., Jone M., Miyasaka M., Ward P. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology. 44:1994;1747-1751.